Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991302 · ClinicalTrials.gov registry record · NA
Durability of Adherence in Self-Management of HIV
A NA study, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT00991302 is a NA study that has completed, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 172 participants.
The verdict
NCT00991302, a NA study, has completed, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
Adherence to highly active antiretroviral therapy (HAART) is critical to successful treatment of HIV. This study tested an intervention that helps people infected with HIV take all their medications when and how they were supposed to.
Interventions
- BEHAVIORAL CAP-IT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991302
The ClinicalTrials.gov registry entry for NCT00991302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CAP-IT is the first listed.
NCT00991302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991302 about?
NCT00991302 is a clinical study titled "Durability of Adherence in Self-Management of HIV". Adherence to highly active antiretroviral therapy (HAART) is critical to successful treatment of HIV. This study tested an intervention that helps people infected with HIV take all their medications when and how they were supposed to.
What is the current status of trial NCT00991302?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2010-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00991302?
The interventions under investigation include: CAP-IT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00991302?
This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.